Therefore, the pathogenic role of GRP, if any, in vascular calcification in patients with CKD and the possible strain differences found in various mouse models [48] need to be carefully considered before targeting GRP in the treatment of human CKD. The gene discussed is GRP; the disease is chronic kidney disease.